Bone Marrow TransplantationTransplantation, AutologousBone MarrowCombined Modality TherapyBone Marrow CellsAntineoplastic Combined Chemotherapy ProtocolsBone Marrow PurgingTransplantation, HomologousWhole-Body IrradiationGraft vs Host DiseaseCyclophosphamideBone and BonesLymphoma, Non-HodgkinHematopoietic Stem Cell TransplantationLeukemiaCarmustineHematopoietic Stem CellsBone Marrow DiseasesLeukemia, Myeloid, AcuteTransplantation ConditioningMelphalanHodgkin DiseaseAnemia, AplasticColony-Forming Units AssayTreatment OutcomeBusulfanRemission InductionHematopoiesisRecurrenceGraft SurvivalTissue DonorsPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow ExaminationTime FactorsEtoposideCytomegalovirus InfectionsBone Marrow NeoplasmsLeukemia, MyeloidSurvival AnalysisImmunosuppressive AgentsHistocompatibility TestingThiotepaHematologic DiseasesCytarabineImmunosuppressionHematologic NeoplasmsBone RemodelingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveActuarial AnalysisAcute DiseaseHistocompatibilityCyclosporineRetrospective StudiesFollow-Up StudiesStem Cell TransplantationBone TransplantationMice, Inbred C57BLImmunocompromised HostMultiple MyelomaSurvival RateDrug EvaluationDisease-Free SurvivalOpportunistic InfectionsLeukocyte CountLymphomaTransplantation, IsogeneicTransplantation ChimeraMyelodysplastic SyndromesSalvage TherapyAntigens, CD34T-LymphocytesGranulocyte Colony-Stimulating FactorRadiation ChimeraVincristineGranulocytesNeutropeniaGraft RejectionCell DifferentiationHepatic Veno-Occlusive DiseaseCell SeparationCells, CulturedPodophyllotoxinBone DensityAntibodies, MonoclonalMycosesAgranulocytosisFlow CytometryProspective StudiesPolymerase Chain ReactionPrognosisCytomegalovirusGranulocyte-Macrophage Colony-Stimulating FactorKidney TransplantationFatal OutcomeBone ResorptionThrombocytopeniaHLA AntigensLymphocyte DepletionStromal CellsPlatelet Count